SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002489
Filing Date
2023-11-14
Accepted
2023-11-14 16:44:43
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rnaz-20230930x10q.htm   iXBRL 10-Q 1222380
2 EX-31.1 rnaz-20230930xex31d1.htm EX-31.1 10585
3 EX-31.2 rnaz-20230930xex31d2.htm EX-31.2 10327
4 EX-32.1 rnaz-20230930xex32d1.htm EX-32.1 7196
5 EX-32.2 rnaz-20230930xex32d2.htm EX-32.2 7023
  Complete submission text file 0001410578-23-002489.txt   5671604

Data Files

Seq Description Document Type Size
6 EX-101.SCH rnaz-20230930.xsd EX-101.SCH 54185
7 EX-101.CAL rnaz-20230930_cal.xml EX-101.CAL 35644
8 EX-101.DEF rnaz-20230930_def.xml EX-101.DEF 136136
9 EX-101.LAB rnaz-20230930_lab.xml EX-101.LAB 421243
10 EX-101.PRE rnaz-20230930_pre.xml EX-101.PRE 301020
64 EXTRACTED XBRL INSTANCE DOCUMENT rnaz-20230930x10q_htm.xml XML 786932
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40363 | Film No.: 231407371
SIC: 2834 Pharmaceutical Preparations